Gene · 3838
Papers1,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics analysis of TCGA data identifies a taurine metabolism-related subtype classification for predicting prognosis in colon adenocarcinoma. | J Gastrointest Oncol | 2025 | 41220730 | PubTator, text mining | PubMed |
| The deubiquitination enzyme USP14 promotes the tumourigenesis of gastric cancer by enhancing c-MYC nuclear translocation through deubiquitination of KPNA2. | Cell Death Dis | 2025 | 41120255 | PubTator, text mining | PubMed |
| Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status. | Open Life Sci | 2025 | 41079598 | PubTator, text mining | PubMed |
| Exploring the impact of antibody-dependent cellular phagocytosis-related genes on the prognosis of metastatic melanoma. | PLoS One | 2025 | 41066319 | PubTator, text mining | PubMed |
| Structural Insights into the Nuclear Import of Haliotid Herpesvirus 1 Large Tegument Protein Homologue. | Viruses | 2025 | 41012706 | PubTator, text mining | PubMed |
| Computational Analysis of Exosome-Derived Signature in TNBC: Integrating Single-Cell and Bulk Transcriptomics for Prognosis Prediction. | Clin Transl Sci | 2025 | 40994257 | PubTator, text mining | PubMed |
| Molecular and Genetic Markers for Malignant Melanoma: Implications for Prognosis and Therapy. | Dermatopathology (Basel) | 2025 | 40981345 | PubTator, text mining | PubMed |
| KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair. | Oncogene | 2025 | 40968253 | PubTator, text mining | PubMed |
| Immunogenic Cell Death Genes Related Prognostic Biomarker in Hepatocellular Carcinoma. | Oncol Res | 2025 | 40918463 | PubTator, text mining | PubMed |
| KPNA2 expression as a biomarker for immunosuppressive microenvironment predicting response to TKI and immunotherapy in metastatic renal cell carcinoma. | Eur J Pharmacol | 2025 | 40912513 | PubTator, text mining | PubMed |
| Investigation and Distinction of Energy Metabolism in Proliferating Hepatocytes and Hepatocellular Carcinoma Cells. | Cells | 2025 | 40862732 | PubTator, text mining | PubMed |
| Identification of RNA binding protein genes associated with colorectal cancer by bioinformatics analysis. | Discov Oncol | 2025 | 40841484 | PubTator, text mining | PubMed |
| USP5-Rich Apoptotic Extracellular Vesicles Regulate Nucleus Pulposus Cells Apoptosis and DNA Damage Repair by Preventing E2F1 Proteasomal Degradation. | J Extracell Vesicles | 2025 | 40831373 | PubTator, text mining | PubMed |
| Coordinating oncogenesis and immune evasion: KPNA2, GOLM1, and TK1 as novel CAR T-cell targets in lung adenocarcinoma. | Eur J Med Res | 2025 | 40830974 | PubTator, text mining | PubMed |
| MiR-20a-5p Inhibits Bladder Cancer Proliferation and Migration by Targeting KPNA2. | J Cell Mol Med | 2025 | 40830912 | PubTator, text mining | PubMed |
| KPNA2 promotes lung adenocarcinoma progression by inducing glycolysis-assisted MYC nuclear translocation. | Cytotechnology | 2025 | 40785975 | PubTator, text mining | PubMed |
| Protein targets & therapeutics in psoriasis: toward personalization. | Int Immunopharmacol | 2025 | 40784273 | PubTator, text mining | PubMed |
| Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. | Nat Commun | 2025 | 40759645 | PubTator, text mining | PubMed |
| LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy. | Oncogene | 2025 | 40721659 | PubTator, text mining | PubMed |
| Natural mutations in key NLS amino acids regulate nucleoplasmic shuttling and replication efficiency in PRRSV. | Front Microbiol | 2025 | 40687856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3838/papers?page=3